Moberg Pharma AB interim report January – March 2019

Booking.com

DIVESTED OTC BUSINESS – TIME FOR MOBERG PHARMA 2.0
FIRST QUARTER (JAN-MAR 2019)

· Net profit after tax SEK 563.9 million (2.0)
· Total profit for the period SEK 504.5 million (5.6)
· Diluted earnings per share SEK 31.95 (0.12)
· Net revenue SEK 15.6 million (0.0) *
· EBITDA SEK 7.3 million (-10.0) *
· Operating profit (EBIT) SEK 5.0 million (-10.0) *
· Operating cash flow per share SEK 1.45 (0.66)
·  Cash and cash equivalents amounted to SEK 1 596.9 million (102.5)  

* represents continuing operations only

SIGNIFICANT EVENTS IN THE FIRST QUARTER

Booking.com

· On

Source: Moberg Pharma AB interim report January – March 2019

Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.